Cost Effectiveness of Colorectal Cancer Screening Strategies in Middle- and High-Income Countries: A Systematic Review
- PMID: 39817422
- DOI: 10.1111/jgh.16882
Cost Effectiveness of Colorectal Cancer Screening Strategies in Middle- and High-Income Countries: A Systematic Review
Abstract
Background and aim: Colorectal cancer (CRC) is a significant global health burden, and screening can greatly reduce CRC incidence and mortality. Previous studies investigated the economic effects of CRC screening. We performed a systematic review to provide the cost-effectiveness of CRC screening strategies across countries with different income levels.
Methods: We searched relevant scientific databases (PubMed, Embase, Ovid, Web of Science, Scopus) from January 1, 2010, to December 31, 2023. We selected English-language studies related to model-based economic evaluations of CRC screening strategies. Information such as the characters of screening tests, model characteristics, and key cost-effectiveness findings were collected. The net monetary benefit approach was used to compare the outcomes of various strategies.
Results: A total of 56 studies were identified, including 46 from high-income countries (HICs), 6 from upper-middle-income countries (UMICs), and 4 from lower-middle-income countries (LMICs). Most annual fecal occult blood tests and fecal immunochemical tests were cost-saving, and colonoscopy every 10 years was cost-saving. Other strategies involving multitarget fecal FIT-DNA detection, computed tomography colonography, and flexible sigmoidoscopy were cost-effective compared with no screening. Newer strategies such as magnetic resonance colonography every 5 years, annual urine metabolomic tests, and fecal bacterial biomarkers were cost-effective compared with no screening.
Conclusion: In our updated review, we found that common CRC screening strategies and magnetic resonance colonography continued to be cost-effective compared with no screening. Areas for further development include accurately modeling the natural history of colorectal cancer and obtaining more evidence from UMICs and LMICs.
Keywords: colorectal cancer; cost effectiveness; microsimulation; screening strategies.
© 2025 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
Similar articles
-
Cost Effectiveness of Colorectal Cancer Screening Strategies.Cancer Control. 2015 Apr;22(2):248-58. doi: 10.1177/107327481502200219. Cancer Control. 2015. PMID: 26068773 Review.
-
Cost-Effectiveness of Colorectal Cancer Screening Strategies-A Systematic Review.Clin Gastroenterol Hepatol. 2019 Sep;17(10):1969-1981.e15. doi: 10.1016/j.cgh.2019.01.014. Epub 2019 Jan 16. Clin Gastroenterol Hepatol. 2019. PMID: 30659991
-
Cost-effectiveness of colorectal cancer screening - an overview.Best Pract Res Clin Gastroenterol. 2010 Aug;24(4):439-49. doi: 10.1016/j.bpg.2010.04.004. Best Pract Res Clin Gastroenterol. 2010. PMID: 20833348 Free PMC article.
-
Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.J Med Econ. 2019 Dec;22(12):1351-1361. doi: 10.1080/13696998.2019.1674065. Epub 2019 Oct 12. J Med Econ. 2019. PMID: 31560247
-
Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations.Radiology. 2011 Nov;261(2):487-98. doi: 10.1148/radiol.11102411. Epub 2011 Aug 3. Radiology. 2011. PMID: 21813740 Free PMC article.
Cited by
-
Acceptability of a Colorectal Cancer-Preventive Diet Promoting Red Meat Reduction and Increased Fiber and Micronutrient Intake: A Cross-Sectional Study in Romanian Adults.Nutrients. 2025 Jul 21;17(14):2386. doi: 10.3390/nu17142386. Nutrients. 2025. PMID: 40733011 Free PMC article.
References
-
- H. Sung, J. Ferlay, R. L. Siegel, et al., “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA: A Cancer Journal for Clinicians 71, no. 3 (2021): 209–249.
-
- N. Li, B. Lu, C. Luo, et al., “Incidence, Mortality, Survival, Risk Factor and Screening of Colorectal Cancer: A Comparison Among China, Europe, and Northern America,” Cancer Letters 522 (2021): 255–268.
-
- Cancer IAfRo. Globocan 2020: Cancer Fact Sheets‐Colorectal Cancer. (2020).
-
- N. Keum and E. Giovannucci, “Global Burden of Colorectal Cancer: Emerging Trends, Risk Factors and Prevention Strategies,” Nature Reviews. Gastroenterology & Hepatology 16, no. 12 (2019): 713–732.
-
- P. Kanth and J. M. Inadomi, “Screening and Prevention of Colorectal Cancer,” BMJ 374 (2021): n1855.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical